Core Viewpoint - Guangdong Province has issued an action plan to accelerate the high-quality development of the nuclear medicine industry from 2025 to 2030, focusing on innovation and collaboration in the sector [1]. Group 1: Development Goals - By 2030, Guangdong aims to significantly enhance its independent innovation capabilities in the nuclear medicine industry, break through key technologies, and establish several innovation platforms [1]. - The plan includes ensuring stable supply of commonly used medical isotopes and advancing a number of radiopharmaceuticals and high-end nuclear medical equipment to clinical trial stages [1]. - The goal is to achieve full coverage of nuclear medicine departments in tertiary general hospitals and cultivate 3-5 leading nuclear medicine enterprises with national influence, along with a number of specialized and innovative companies [1]. Group 2: Collaboration and Innovation - The plan encourages establishing cooperative mechanisms with major medical isotope-producing countries and promotes joint research in radiopharmaceutical development with international research institutions [1]. - There is a strong emphasis on supporting the innovation and research of radiopharmaceuticals, encouraging investments from enterprises, healthcare institutions, universities, and research institutes [1]. Group 3: Talent Development - The plan supports the optimization of academic programs in key universities such as Sun Yat-sen University and Jinan University to develop nuclear medicine specialties, including radiology, nuclear medicine, radiochemistry, and radiation protection [2].